Capricorn Fund Managers Ltd Purchases New Shares in Sotera Health Company $SHC

Capricorn Fund Managers Ltd purchased a new position in Sotera Health Company (NASDAQ:SHC) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 449,900 shares of the company’s stock, valued at approximately $7,936,000. Sotera Health makes up 1.9% of Capricorn Fund Managers Ltd’s investment portfolio, making the stock its 15th biggest position. Capricorn Fund Managers Ltd owned approximately 0.16% of Sotera Health as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. Nordea Investment Management AB acquired a new position in Sotera Health in the 4th quarter worth approximately $1,908,000. Exchange Traded Concepts LLC acquired a new stake in Sotera Health during the 4th quarter valued at $7,739,000. Hudson Bay Capital Management LP purchased a new stake in shares of Sotera Health in the third quarter valued at $3,932,000. Voss Capital LP lifted its holdings in shares of Sotera Health by 50.0% in the second quarter. Voss Capital LP now owns 750,000 shares of the company’s stock valued at $8,340,000 after purchasing an additional 250,000 shares in the last quarter. Finally, CenterBook Partners LP acquired a new stake in shares of Sotera Health in the third quarter worth $1,228,000. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Price Performance

SHC stock opened at $14.96 on Monday. The firm has a market cap of $4.25 billion, a PE ratio of 55.41 and a beta of 1.88. Sotera Health Company has a 1 year low of $9.53 and a 1 year high of $19.85. The company has a fifty day simple moving average of $15.85 and a 200 day simple moving average of $16.53. The company has a current ratio of 2.46, a quick ratio of 2.24 and a debt-to-equity ratio of 3.66.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, February 24th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. The firm had revenue of $303.44 million for the quarter, compared to the consensus estimate of $300.68 million. During the same period in the prior year, the business posted $0.21 earnings per share. The business’s quarterly revenue was up 4.6% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Sell-side analysts anticipate that Sotera Health Company will post 0.61 EPS for the current fiscal year.

Insider Buying and Selling at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the firm’s stock in a transaction that occurred on Friday, March 6th. The stock was sold at an average price of $15.27, for a total value of $152,700,000.00. Following the transaction, the director directly owned 12,735,301 shares of the company’s stock, valued at approximately $194,468,046.27. This trade represents a 43.98% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 47.55% of the company’s stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on the company. Zacks Research lowered Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Royal Bank Of Canada started coverage on Sotera Health in a research note on Thursday, January 8th. They set an “outperform” rating and a $24.00 target price on the stock. William Blair assumed coverage on Sotera Health in a report on Thursday, December 18th. They issued an “outperform” rating on the stock. Citigroup raised their price target on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Finally, Wells Fargo & Company downgraded shares of Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $20.43.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.